NCT03332849View on ClinicalTrials.gov

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

PHASE1UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 28, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Type1 Diabetes MellitusType2 Diabetes Mellitus
Interventions
BIOLOGICAL

HM12470

HM12470 is a long-acting insulin analogue

Trial Locations (1)

91911

Hanmi Investigative Site, Chula Vista

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT03332849 - Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter